|
2025 Conference Publication Long-term oncological and fertility outcomes following the Levonorgestrel intrauterine device in early-stage endometrial adenocarcinoma - results from the Femme Phase II randomised trialBaxter, Eva, Robledo, Kristy, Gebski, Val, Chen, Chen, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James, Chetty, Naven, Janda, Monika and Obermair, Andreas (2025). Long-term oncological and fertility outcomes following the Levonorgestrel intrauterine device in early-stage endometrial adenocarcinoma - results from the Femme Phase II randomised trial. IGCS 2025 Annual Global Meeting, Cape Town, South Africa, 5 - 7 November 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.ijgc.2025.102241 |
|
2024 Conference Publication EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysisObermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551 |
